ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2017

Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community.

Richard Markus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.